## GAIL ECKHARDT

| | Title| Professor  
---|---  
Institution| Baylor College of Medicine  
Department| Department of Medicine  
Address| One Baylor Plaza  
Houston, TX 77030  
  
Email|
![](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/EmailHandler.ashx?msg=Eao57SviI4D9R53p9FvAKbnCIhWf&rnd=0fc27722-f2df-485b-80fc-731b50f1bf46)  
vCard| [Download
vCard](https://profiles.viictr.org/profile/modules/CustomViewPersonGeneralInfo/vcard.aspx?subject=41109789)  
  

Other Positions| Title| Professor  
---|---  
Institution| Baylor College of Medicine  
Department| Duncan Cancer Center  
Division| Cancer Center  
  
  
  
  
![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
Bibliographic  

![Collapse](https://profiles.viictr.org/Profile/Modules/PropertyList/images/minusSign.gif)
selected publications

Publications listed below are automatically derived from MEDLINE/PubMed and
other sources, which might result in incorrect or missing publications.
Faculty can
[login](https://profiles.viictr.org/loginOptions.aspx?pin=send&method=login&edit=true)
to make corrections and additions.

Newest | Oldest | Most Cited | Most Discussed | Timeline | Field Summary | Plain Text

PMC Citations indicate the number of times the publication was cited by
articles in PubMed Central, and the Altmetric score represents citations in
news articles and social media. (Note that publications are often cited in
additional ways that are not shown here.) Fields are based on how the National
Library of Medicine (NLM) classifies the publication's journal and might not
represent the specific topic of the publication. Translation tags are based on
the publication type and the MeSH terms NLM assigns to the publication. Some
publications (especially newer ones and publications not in PubMed) might not
yet be assigned Field or Translation tags.) Click a Field or Translation tag
to filter the publications.

  1. Weiss JA, Nicklawsky A, Kagihara JA, Gao D, Fisher C, Elias A, Borges VF, Kabos P, Davis SL, Leong S, **Eckhardt SG** , Diamond JR. Clinical outcomes of breast cancer patients treated in phase I clinical trials at University of Colorado Cancer Center. Cancer Med. 2020 12; 9(23):8801-8808. PMID: [33063469](//www.ncbi.nlm.nih.gov/pubmed/33063469); PMCID: [PMC7724484](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7724484).

Citations:

  2. Capasso A, Pitts TM, Klauck PJ, Bagby SM, Westbrook L, Kaplan J, Soleimani M, Spreafico A, Tentler JJ, Diamond JR, Arcaroli JJ, Messersmith WA, **Eckhardt SG** , Leong S. Dual compartmental targeting of cell cycle and angiogenic kinases in colorectal cancer models. Anticancer Drugs. 2018 10; 29(9):827-838. PMID: [30048249](//www.ncbi.nlm.nih.gov/pubmed/30048249); PMCID: [PMC6143222](//www.ncbi.nlm.nih.gov/pmc/articles/PMC6143222).

Citations:

  3. [Ferrarotto R](https://profiles.viictr.org/profile/12583155), **Eckhardt G** , Patnaik A, LoRusso P, Faoro L, [Heymach JV](https://profiles.viictr.org/profile/12582703), Kapoun AM, Xu L, Munster P. A phase I dose-escalation and dose-expansion study of brontictuzumab in subjects with selected solid tumors. Ann Oncol. 2018 07 01; 29(7):1561-1568. PMID: [29726923](//www.ncbi.nlm.nih.gov/pubmed/29726923).

Citations:
[29](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/29726923/citedby/) Fields:

Neo Neoplasms

Translation:HumansCTClinical Trials

  4. [Ferrarotto R](https://profiles.viictr.org/profile/12583155), [Mitani Y](https://profiles.viictr.org/profile/17439989), Diao L, Guijarro I, Wang J, Zweidler-McKay P, [Bell D](https://profiles.viictr.org/profile/12583490), William WN, [Glisson BS](https://profiles.viictr.org/profile/12583250), Wick MJ, Kapoun AM, Patnaik A, **Eckhardt G** , Munster P, Faoro L, Dupont J, Lee JJ, [Futreal A](https://profiles.viictr.org/profile/12583608), [El-Naggar AK](https://profiles.viictr.org/profile/12582532), [Heymach JV](https://profiles.viictr.org/profile/12582703). Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors. J Clin Oncol. 2017 Jan 20; 35(3):352-360. PMID: [27870570](//www.ncbi.nlm.nih.gov/pubmed/27870570); PMCID: [PMC5456373](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5456373).

Citations:
[50](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/27870570/citedby/) Fields:

Neo Neoplasms

Translation:HumansAnimalsCells

  5. Oweida A, Bhatia S, Hirsch K, Calame D, Griego A, Keysar S, Pitts T, Sharma J, **Eckhardt G** , Jimeno A, Wang XJ, Parkash G, Califano J, Karam SD. Ephrin-B2 overexpression predicts for poor prognosis and response to therapy in solid tumors. Mol Carcinog. 2017 03; 56(3):1189-1196. PMID: [27649287](//www.ncbi.nlm.nih.gov/pubmed/27649287); PMCID: [PMC5939940](//www.ncbi.nlm.nih.gov/pmc/articles/PMC5939940).

Citations:

  6. Arcaroli JJ, Tai WM, McWilliams R, Bagby S, Blatchford PJ, Varella-Garcia M, Purkey A, Quackenbush KS, Song EK, Pitts TM, Gao D, Lieu C, McManus M, Tan AC, Zheng X, Zhang Q, Ozeck M, Olson P, Jiang ZQ, Kopetz S, Jimeno A, Keysar S, **Eckhardt G** , Messersmith WA. A NOTCH1 gene copy number gain is a prognostic indicator of worse survival and a predictive biomarker to a Notch1 targeting antibody in colorectal cancer. Int J Cancer. 2016 Jan 01; 138(1):195-205. PMID: [26152787](//www.ncbi.nlm.nih.gov/pubmed/26152787); PMCID: [PMC4618491](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4618491).

Citations:

  7. Song EK, Tai WM, Messersmith WA, Bagby S, Purkey A, Quackenbush KS, Pitts TM, Wang G, Blatchford P, Yahn R, Kaplan J, Tan AC, Atreya CE, **Eckhardt G** , Kelley RK, Venook A, Kwak EL, Ryan D, Arcaroli JJ. Potent antitumor activity of cabozantinib, a c-MET and VEGFR2 inhibitor, in a colorectal cancer patient-derived tumor explant model. Int J Cancer. 2015 Apr 15; 136(8):1967-75. PMID: [25242168](//www.ncbi.nlm.nih.gov/pubmed/25242168); PMCID: [PMC4323738](//www.ncbi.nlm.nih.gov/pmc/articles/PMC4323738).

Citations:

  8. Micel LN, Tentler JJ, Smith PG, **Eckhardt GS**. Role of ubiquitin ligases and the proteasome in oncogenesis: novel targets for anticancer therapies. J Clin Oncol. 2013 Mar 20; 31(9):1231-8. PMID: [23358974](//www.ncbi.nlm.nih.gov/pubmed/23358974); PMCID: [PMC3807137](//www.ncbi.nlm.nih.gov/pmc/articles/PMC3807137).

Citations:

  9. Infante JR, Fecher LA, Falchook GS, Nallapareddy S, Gordon MS, Becerra C, DeMarini DJ, Cox DS, Xu Y, Morris SR, Peddareddigari VG, Le NT, Hart L, Bendell JC, **Eckhardt G** , Kurzrock R, Flaherty K, Burris HA, Messersmith WA. Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial. Lancet Oncol. 2012 Aug; 13(8):773-81. PMID: [22805291](//www.ncbi.nlm.nih.gov/pubmed/22805291).

Citations:

  10. Philip PA, Mooney M, Jaffe D, **Eckhardt G** , Moore M, Meropol N, Emens L, O'Reilly E, Korc M, [Ellis L](https://profiles.viictr.org/profile/12583649), Benedetti J, Rothenberg M, Willett C, Tempero M, Lowy A, Abbruzzese J, Simeone D, Hingorani S, Berlin J, Tepper J. Consensus report of the national cancer institute clinical trials planning meeting on pancreas cancer treatment. J Clin Oncol. 2009 Nov 20; 27(33):5660-9. PMID: [19858397](//www.ncbi.nlm.nih.gov/pubmed/19858397); PMCID: [PMC7587401](//www.ncbi.nlm.nih.gov/pmc/articles/PMC7587401).

Citations:
[100](https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19858397/citedby/)
Fields:

Neo Neoplasms

Translation:HumansAnimals

  11. de Bono JS, Rha SY, Stephenson J, Schultes BC, Monroe P, **Eckhardt GS** , Hammond LA, Whiteside TL, Nicodemus CF, Cermak JM, Rowinsky EK, Tolcher AW. Phase I trial of a murine antibody to MUC1 in patients with metastatic cancer: evidence for the activation of humoral and cellular antitumor immunity. Ann Oncol. 2004 Dec; 15(12):1825-33. PMID: [15550589](//www.ncbi.nlm.nih.gov/pubmed/15550589).

Citations:

This graph shows the total number of publications by year. To see the data as
text, click here.

![Bar chart showing 11 publications over 9 distinct years, with a maximum of 2
publications in 2016 and
2018](//chart.googleapis.com/chart?chs=595x100&chf=bg,s,ffffff|c,s,ffffff&chxt=x,y&chxl=0:|'94||'96||'98||'00||'02||'04||'06||'08||'10||'12||'14||'16||'18||'20||'22||'24|1:|0|2&cht=bvs&chd=t:0,0,0,0,0,0,0,0,0,0,50,0,0,0,0,50,0,0,50,50,50,50,100,0,100,0,50,0,0,0,0&chdl=Publications&chco=80B1D3&chbh=10)

This graph shows the total number of publications by year. To return to the
graph, click here.

Year| Publications  
---|---  
2004| 1  
2009| 1  
2012| 1  
2013| 1  
2014| 1  
2015| 1  
2016| 2  
2018| 2  
2020| 1  
  
This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

This graph shows the number and percent of publications by field. Fields are
based on how the National Library of Medicine (NLM) classifies the
publications' journals and might not represent the specific topics of the
publications. Note that an individual publication can be assigned to more than
one field. As a result, the publication counts in this graph might add up to
more than the number of publications the person has written. To see the data
as text, click here.

Start with: newest oldest Include: line numbers double spacing all authors
publication IDs

ECKHARDT's Networks

Click the

Explore

buttons for more information and interactive visualizations!

Concepts (130)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

Derived automatically from this person's publications.

  * [Ubiquitin-Activating Enzymes](https://profiles.viictr.org/profile/253461)
  * [Ubiquitin-Conjugating Enzymes](https://profiles.viictr.org/profile/250812)
  * [Receptor, Notch1](https://profiles.viictr.org/profile/241503)
  * [Proteasome Endopeptidase Complex](https://profiles.viictr.org/profile/259913)
  * [Ubiquitin-Protein Ligases](https://profiles.viictr.org/profile/239949)

[Explore](https://profiles.viictr.org/profile/41109789/198)

_

Co-Authors (8)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People in Profiles who have published with this person.

  * [FERRAROTTO, RENATA](https://profiles.viictr.org/profile/12583155)
  * [HEYMACH, JOHN VICTOR](https://profiles.viictr.org/profile/12582703)
  * [GLISSON, BONNIE S](https://profiles.viictr.org/profile/12583250)
  * [EL-NAGGAR, ADEL K](https://profiles.viictr.org/profile/12582532)
  * [BELL, DIANA](https://profiles.viictr.org/profile/12583490)

[Explore](https://profiles.viictr.org/profile/41109789/345)

_

Similar People (60)
![](https://profiles.viictr.org/profile/modules/passivelist/Images/info.png)

People who share similar concepts with this person.

  * [KANTARJIAN, HAGOP M](https://profiles.viictr.org/profile/12582901)
  * [CORTES, JORGE E](https://profiles.viictr.org/profile/12582539)
  * [JABBOUR, ELIAS JOSEPH](https://profiles.viictr.org/profile/12583425)
  * [VAUTHEY, JEAN NICOLAS](https://profiles.viictr.org/profile/12582959)
  * [HONG, DAVID SANGHYUN](https://profiles.viictr.org/profile/12583776)

[Explore](https://profiles.viictr.org/profile/41109789/476)

_

Same Department [ ![Expand
Description](https://profiles.viictr.org/Framework/Images/info.png)
](JavaScript:toggleVisibility\('sdDescript'\);)

People who are also in this person's primary department.

  * [DIAMOND, AKIVA](https://profiles.viictr.org/profile/31721883)
  * [HUANG, QUILLAN](https://profiles.viictr.org/profile/17411326)
  * [LIU, HAO](https://profiles.viictr.org/profile/265543)
  * [PATEL, MEERA](https://profiles.viictr.org/profile/35507209)
  * [RIMAWI, MOTHAFFAR](https://profiles.viictr.org/profile/269416)

[Explore](https://profiles.viictr.org/search/default.aspx?searchtype=people&searchfor=&SearchRequest=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)

_

